Original document(33 pages)  中文版
    The invention provides dosage forms of a compound of formula (1) or pharmaceutically acceptable salts, solvates or prodrugs thereof. The invention further provides methods of treating abnormal cell growth, such as cancers, by admnistering the dosage forms to a mammal.
Application Number
申请号		 200480008794 Application Date
申请日		 2004.03.17
Title 名称 Dosage forms comprising ag013736
Publication Number
公开号		 1832743 Publication Date
公开日		 2006.09.13
Approval Pub. Date Granted Pub. Date
International Classification 分类号 A61K31/4439,A61K31/337,A61P35/00
Applicant(s) Name
申请人		 Agouron Pharma
Address 地址
Inventor(s) Name 发明人 Freddo James, Hu-Lowe Dana, Pithavala Yazdi Kersi
Attorney & Agent 代理人 zhang bengyuan zhao renlin

  
Treatment for alzheimer's disease and related conditions
2-'4(phenylamino)-piperidin-1-yl!-n-phenyl-acetamine derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatement of obesity
Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections
Combinations comprising staurosporines
Homogeneous, thermoreversible gel containing reduced viscosity carrageenan and products made therefrom
Viscosity-Stable bismuth-containing pharmaceutical compositions.
Effects of sporoderm-broken germination activated ganoderma spores on treatment of spinal cord injury and proliferation and/or differentiation of neural stem cells in injured spinal cord
Periodontal disease therapeutic and/or preventive composition
Nogo-receptor antagonists for the treatment of conditions involving amyloid plaques
Ghrelin analogs
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.